Recent Finacing
Recent Raise
Tepha develops and commercializes biosynthetically produced resorbable polyhydroxyalkanoate (PHA) biomaterials and manufactures FDA-cleared absorbable sutures, meshes, films, and composite implants while developing absorbable stents and cardiac and orthopedic devices.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor